Literature DB >> 2081498

Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humans.

M A Brett1, G Buscher, E Ellrich, W H Greb, H J Kurth, G Rülander, B Schmerenbeck, R E Haddock, A R Thawley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2081498     DOI： 10.2165/00003495-199000405-00017

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  2 in total

1.  Metabolism of nabumetone (BRL 14777) by various species including man.

Authors:  R E Haddock; D J Jeffery; J A Lloyd; A R Thawley
Journal:  Xenobiotica       Date:  1984-04       Impact factor: 1.908

2.  Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.

Authors:  E A Boyle; P C Freeman; F R Mangan; M J Thomson
Journal:  J Pharm Pharmacol       Date:  1982-09       Impact factor: 3.765
  2 in total
  2 in total

Review 1.  Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

2.  Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.

Authors:  H A Friedel; H D Langtry; M M Buckley
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.